Inventor · disambiguated record
Satoshi Nagayama
Also filed as: NAGAYAMA SATOSHI
8 granted patents·3 pending applications·18 citations·filing 2005–2009
81Inventor score
Top patents by PatentIndex Score
11 records- 0182US7214824B2Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonistsPFIZER·Filed 2005·Granted May 8, 2007·5 cites·10 claims
- 0278US7514457B2Substituted aryloxymethyl bicyclicmethyl acetamide compoundsPFIZER·Filed 2006·Granted Apr 7, 2009·4 cites·10 claims
- 0376US7566739B2Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonistsPFIZER·Filed 2006·Granted Jul 28, 2009·3 cites·12 claims
- 0475US7915448B2Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonistsPFIZER·Filed 2009·Granted Mar 29, 2011·2 cites·13 claims
- 0571US7622589B2Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonistsPFIZER·Filed 2006·Granted Nov 24, 2009·1 cites·10 claims
- 0670US8134004B2Substituted N-bicyclicalkyl bicycliccarboxyamide compoundsKAWASHIMA TADASHI·Filed 2007·Granted Mar 13, 2012·2 cites·12 claims
- 0764US8178558B2Substituted pyridylmethyl bicycliccarboxyamide compoundsNAGAYAMA SATOSHI·Filed 2007·Granted May 15, 2012·1 cites·12 claims
- 0853US2010190685A1Prognostic factor in sarcoma, and metastasis inhibitorUNIV KYOTO·Filed 2008·Application pending·0 cites
- 0949US8153651B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameCOX MATTHEW·Filed 2008·Granted Apr 10, 2012·0 cites·54 claims
- 1044US2012088746A1Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameSHISHIDO YUJI·Filed 2007·Application pending·0 cites
- 1140US2011152326A1Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonistsHANAZAWA TAKESHI·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Satoshi Nagayama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →